Skip To Content
Search
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Type
All
AllStoriesVideoAudioGraphicsBusinessweek
Sort
By Relevance
By RelevanceBy NewestBy Oldest
Time
Any Time
Any TimeLast 24 HoursPast WeekPast Month

Showing results for "Frequency Therapeutics"

relates to Where to Invest $1 Million Now: Big-Cap Stocks, Distressed Tech, Blockchain
wealth
Where to Invest $1 Million Now: Big-Cap Stocks, Distressed Tech, Blockchain
By Suzanne Woolley, Claire Ballentine, Brian Chappatta, Benjamin Stupples, Felipe Marques, and Devon Pendleton
Six experts offer timely ideas on where to deploy a big chunk of cash.
June 24, 2022
business
BioCryst Rises as Experimental Gout Medicine Helps Patients
By Margaret Tirrell
BioCryst Pharmaceuticals Inc. gained 6.2 percent after a study showed that adding the drugmaker’s gout medicine to a standard therapy lowered patients’ uric acid levels better than the usual treatment.
November 8, 2011
relates to Novartis’s Multiple Sclerosis Pill Faces FDA Review
business
Novartis’s Multiple Sclerosis Pill Faces FDA Review
Novartis AG’s drug Gilenia has risks that may outweigh its benefit in treating multiple sclerosis, according to U.S. regulators reviewing whether to approve the first pill to slow progression of the disease.
June 8, 2010
business
Theravance, Targanta Shares Soar on FDA Review of Antibiotics
New drugs developed by Theravance Inc. and Targanta Therapeutics Corp. may help fight MRSA, an infection that kills 19,000 Americans a year, U.S. regulators said, sending the companies soaring in Nasdaq trading.
November 17, 2008
relates to Fauci Floats Three Doses; U.S. Hospitals Strained: Virus Update
politics
Fauci Floats Three Doses; U.S. Hospitals Strained: Virus Update
By Ian Fisher
Three doses of Covid-19 vaccine may become the standard regimen for most people, White House chief medical adviser Anthony Fauci said. His comments came as medical experts who advise U.S. regulators on vaccines are chafing at what they perceive as political interference by the Biden administration in the review process of booster shots.
September 2, 2021
relates to Time to Reset Expectations for World Economy With Virus Untamed
business
Time to Reset Expectations for World Economy With Virus Untamed
By Enda Curran, Suzi Ring, and Anchalee Worrachate
Investors banking on a coronavirus vaccine to save the world economy in 2021 need to temper their ambitions as scientists increasingly warn of a long and difficult road ahead.
October 25, 2020
business
The Bloomberg Baystate Business Hour: Bosox and Biotech
Bloomberg Boston Bureau Chief Tom Moroney and Radio News Anchor Peter Barnes are joined by top names from local business and finance to medicine and politics, along with Bloomberg reporters covering the latest stories in and around Boston. Today: news and market checks from Pimm Fox, then Tom and Peter discuss the firing of Red Sox manager John Farrell with Smith College sports economics expert Andrew Zimbalist, the gender gap in life sciences with Mass. Biotech Chair Abbie Celniker, and our C
October 11, 2017
opinion
Mergers, Spinoffs and CDS
By Matthew S Levine
Also blockchains, bond-fund marketing, oil reserves, unicorns and Jeff Skilling.
December 10, 2015
relates to When Big Business Happens to Your Pet
business
When Big Business Happens to Your Pet
By Jason Clenfield
A wave of corporatization is hitting the veterinary industry, but does a one-size-fits-all approach work?
January 5, 2017
relates to Drugmakers Try Gels, Gene Therapy to Help Reverse Hearing Loss
business
Drugmakers Try Gels, Gene Therapy to Help Reverse Hearing Loss
By Caroline Chen and Doni Bloomfield
Sarah Povey spent her youth at rock concerts, sometimes going out five or six nights in a row, soaking up the live sound from nearby speakers. By her late 20s, she was diagnosed with severe tinnitus, a ringing in the ear that makes it hard to listen to any music at all.
October 14, 2016